Advertisement

Better Biotech Stock: Moderna vs. BioNTech

Better Biotech Stock: Moderna vs. BioNTech

Not only did they develop the first two COVID vaccines authorized by the Food and Drug Administration, they used messenger RNA (mRNA). The technology had never been approved for a vaccine in humans. Moderna went public in 2018 in what was to that point the largest biotech initial public offering (IPO) in history.